• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-18

  Oh et al. establish a scalable human model in which hiPSCs are rapidly differentiated into functional sensory neurons and infected with HSV-1 under latent conditions. The model reproduces multiple hallmarks of neuronal latency, including the absence of infectious virus, reduced lytic transcription, latency-associated transcript expression, viral heterochromatin, and reactivation after forskolin or PI3K inhibition.

• MCC950 sodium: NLRP3 Workflow Guide

  2026-08-18

  MCC950 sodium, also known as CRID3 sodium salt, provides a selective way to test whether NLRP3 drives cytokine release and pyroptosis rather than relying on broad anti-inflammatory effects. This guide translates its use from oxidative-stress endothelial assays to macrophage, PBMC, endotoxemia, and autoimmune disease workflows, with practical controls and troubleshooting.

• GntR Phosphorylation in Streptococcus suis Virulence

  2026-08-17

  The reference study identifies a phosphorylation-dependent switch in which the Streptococcus suis serotype 2 kinase STK modifies the GntR transcription factor at Ser-41, suppressing nox transcription and weakening oxidative-stress resistance. Its integrated genetic, biochemical, transcriptional, redox, and infection models connect a specific phosphorylation event to NADH accumulation and reduced virulence, providing a useful framework for protein phosphorylation signaling research.

• Live-Dead Bacterial Staining Kit: Viability Guide

  2026-08-17

  The Live-Dead Bacterial Staining Kit uses NucGreen dye and EthD-III to distinguish bacteria with intact membranes from bacteria with compromised membranes. This dual-fluorescence bacterial viability assay supports research measurement of bacterial live-dead differentiation, but it does not replace culture, molecular identification, or clinical diagnosis.

• Exosomal Egr2, RNF8/DAPK1, and Ischemic Stroke

  2026-08-16

  The reference study identifies a mechanistic pathway in which Egr2 carried by bone marrow mesenchymal stem cell exosomes protects OGD/R-injured neuronal cells through transcriptional activation of RNF8 and suppression of DAPK1. Its layered use of exosome characterization, promoter assays, rescue experiments, and Co-IP provides a useful framework for evaluating protein and regulatory networks, although validation remains limited to an in vitro neuronal injury model.

• Anti-Diabetic Drugs and Fracture Risk

  2026-08-15

  This systematic review and network meta-analysis integrates randomized evidence to compare fracture outcomes across anti-diabetic drug classes and individual agents in type 2 diabetes. Its main practical contribution is a more comparative safety framework: trelagliptin showed a statistically significant increase in fracture risk, whereas voglibose and albiglutide showed lower risk, while most other agents—including ertugliflozin—did not differ significantly from comparators.

• Ivermectin Workflows for Parasitology Research

  2026-08-14

  Ivermectin is a broad-spectrum anti-parasitic research compound suited to controlled dose-response, motility, viability, and host-cell selectivity workflows. This guide combines practical formulation advice with assay-design lessons from a Gasdermin C study while clearly separating established parasitology applications from exploratory cancer biology.

• Cryo-EM Reveals HCAR3 Agonist Selectivity

  2026-08-14

  Ye et al. used cryo-EM structures and cellular cAMP assays to define how HCAR3 recognizes several agonists and how its binding pocket differs from HCAR2. The study provides a structural framework for interpreting receptor selectivity and guiding lipid metabolism regulation research without relying solely on HCAR2-associated pharmacology.

• HyperScribe T7 High Yield RNA Synthesis Kit Plus

  2026-08-13

  The HyperScribe T7 High Yield RNA Synthesis Kit Plus streamlines high-output RNA production for mRNA rescue, labeled probes, and functional assays. Its scalable reaction format is especially useful for translating the FLCN mRNA rescue findings in Birt-Hogg-Dubé syndrome into reproducible bench workflows.

• ARCA EGFP mRNA (5-moUTP) Workflow Guide

  2026-08-13

  Build a reproducible fluorescence-based transfection control with capped, modified, polyadenylated mRNA rather than relying solely on plasmid DNA or indirect viability readouts. This guide covers cold-chain handling, dose-finding, mammalian-cell delivery, quantitative EGFP analysis, and storage-informed troubleshooting.

• Bile Acid Subtyping Reveals Immune Markers in CRC

  2026-08-12

  Feng et al. used transcriptomic subtyping to connect bile acid metabolism with immune features, survival, and candidate biomarkers in colorectal cancer. The study prioritizes CLCA1, UGT2A3, and ZG16 for further validation while showing why metabolic subgrouping may help interpret tumor immune heterogeneity.

• How Impending Cell Death Creates Prometastatic States

  2026-08-12

  Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending apoptotic event can enter stable prometastatic states called PAMEs. Their work links ER stress, transcriptional reprogramming, stemness, and cytokine-mediated recruitment to the emergence of a prometastatic tumor ecosystem.

• Deferoxamine mesylate: Assay Workflows

  2026-08-11

  Deferoxamine mesylate gives researchers a practical way to manipulate labile iron while probing oxidative stress, hypoxia signaling, ferroptosis, and tissue-protection phenotypes. This workflow-focused guide connects concentration selection, HIF-1α stabilization, wound healing promotion, and NRF2-linked ferroptosis biology with troubleshooting steps for reproducible assays.

• AZD0156: Translational Leverage in ATM Inhibition

  2026-08-11

  AZD0156 offers translational researchers a highly selective way to interrogate ATM-dependent DNA damage signaling, repair capacity, checkpoint control, and metabolic adaptation. This article connects mechanistic biology with experimental design, combination-strategy development, biomarker selection, and the practical realities of moving ATM inhibition toward cancer therapy research.

• Pazopanib Hydrochloride Cancer Assays

  2026-08-10

  Use Pazopanib Hydrochloride (GW786034) to separate growth arrest from cell killing in tumor, endothelial, and co-culture models. This workflow combines mechanism-aware dose design with time-resolved viability measurements for more interpretable cancer research.

16329 records 1/1089 page Next 12345 下5页 Last page